Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder. Animal studies have demonstrated that impairment of cellular mitochondrial ener-gy metabolism and/ or altered glutamatergic N-methyl-D- asparate recetor-mediated activity can produce neuropathologic changes closely resembling HD. This study will test interventions, coenzyme Q10 and remacemide hydrochloride, that buttress mmitochondrial energy metabolism and attenuate the decline of HD.
Showing the most recent 10 out of 577 publications